HMNY currently hovers at less than 2 cents per share, despite the company’s 1-to-250 reverse stock split in July. By the end of the trading day, the stock was down by 53% and the slump has continued. But investors grew unnerved and dumped the stock. Theoretically, the move should have resulted in a share price of $22.50 (250 times the per-share price just prior to the reverse split). This move was widely seen as the company’s desperate attempt to avoid the stock falling to a level that would cause Nasdaq to de-list it. On July 25, the company conducted a reverse stock split, compacting every 250 shares of its stock already outstanding into just one new share. However, 2018 has been choppy - and disastrous - for HMNY.
In 2017, Helios and Matheson stock gained 102.8%, versus a 19.4% gain for the S&P 500. How Has Helios and Matheson Performed In 2017/2018? The following chart shows HMNY’s historical daily share price over the past five years, adjusted for splits and dividends (up to market close, December 3, 2018): The stock has been extremely volatile and suffered a precipitous decline. Read Also: What’re the best retail stocks to buy? How Has Helios and Matheson Performed?
HELIOS AND MATHESON STOCK BUY OR SELL MOVIE
The service uses a mobile app whereby users check into a cinema and pick the movie and showtime the cost of the ticket is deducted from a prepaid debit card and passed along to the cinema. MoviePass allows subscribers to purchase up to three movie tickets per month for a monthly fee. MoviePass has gotten a lot of press coverage. With a market cap of $27 million, Helios and Matheson also majority owns MoviePass, a subscription-based movie ticketing service. Its clients operate in various industries, including financial services, automotive, insurance, and health care. Helios and Matheson Analytics, based in New York City, provides major corporations a broad variety of information technology (IT) solutions, including infrastructure, information management, and analytics services. “The time to buy is when there’s blood in the streets.” Attributed to the 18th century financier Baron Rothschild, this colorful and often repeated euphemism means that investors in the midst of a severe market downturn should seek inherently strong stocks that have been unfairly driven down in price by the irrational fear of the crowd.ĭoes the Baron’s sentiment apply to Helios and Matheson Analytics? Is the stock an enticing value play? Or is it a landmine that you should sidestep? Below, I sift through this complicated story to get some straight answers.
They see HMNY as a classic contrarian play for investors willing to shoulder some risk. The erstwhile high-flying stock has plummeted and management continually fends off rumors of bankruptcy.īut now, some bargain hunters are licking their chops. One such stock is Helios and Matheson Analytics (NYSE: HMNY), an information technology (IT) firm that owns MoviePass.įounded in 1982, Helios and Matheson has experienced its share of woes and extreme volatility in recent months, going from Wall Street darling to investment pariah.
In their search for value, analysts are starting to tout various distressed stocks, arguing that they’ve been unfairly beaten down and could soon turnaround. In this choppy and still overvalued market, where can you go for stable growth stocks that trade at a bargain?
0 kommentar(er)
